0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Hemostatic Sponge Market Research Report 2026
Published Date: 2026-02-05
|
Report Code: QYRE-Auto-21S7052
Home | Market Reports | Health| Medical Devices & Equipment
Global Hemostatic Sponge Market Insights and Forecast to 2028
BUY CHAPTERS

Global Hemostatic Sponge Market Research Report 2026

Code: QYRE-Auto-21S7052
Report
2026-02-05
Pages:132
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Hemostatic Sponge Market Size

The global Hemostatic Sponge market was valued at US$ 1620 million in 2025 and is anticipated to reach US$ 2109 million by 2032, at a CAGR of 4.1% from 2026 to 2032.

Hemostatic Sponge Market

Hemostatic Sponge Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Hemostatic Sponge competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Hemostatic Sponges are topical hemostatic medical consumables used for local hemostasis in surgical or traumatic wounds. They achieve rapid hemostasis by absorbing blood and providing a porous scaffold to promote platelet aggregation and clot formation. Their material systems can include gelatin, collagen, oxidized regenerated cellulose, or composite matrices, emphasizing absorption speed and porosity to enhance hemostatic efficiency. Some products can be used in combination with thrombin to further enhance hemostatic effects. These products are widely used in general surgery, orthopedics, neurosurgery, ENT, dentistry, and emergency care. Key performance requirements include biocompatibility, sterility assurance, predictable absorbability or removability, low endotoxin levels, and controllable expansion to avoid pressure on surrounding tissues. The hemostatic sponge supply chain includes upstream bio-based polymer raw materials (gelatin/collagen/cellulose, etc.), purification reagents, cross-linking agents, medical-grade water, sterilization consumables, packaging materials, and labeling materials. The midstream manufacturing process encompasses raw material processing, foaming or freeze-drying to create porous structures, molding and cutting, drying, sterilization (using gamma or ethylene oxide), and quality testing for absorbency, endotoxins, bioburden, and mechanical integrity. Downstream users primarily include hospitals, surgical centers, trauma departments, and medical device distribution channels. Supporting services include clinical use training, regulatory documentation support, post-market surveillance, and aseptic logistics supply assurance.
Prices for Medical Haemostatic Sponges vary widely by brand tier, sponge format (sheet vs. dental cubes), sterility/pack configuration, and the procurement channel (hospital contract vs. retail). The gross profit margin of major companies in the industry is between 10% – 30%.
The Hemostatic Sponge market is expanding as surgical volumes rise and hospitals emphasize faster, safer bleeding control to reduce operating time and complications. Demand spans routine procedures and high-risk surgeries, with growing use in minimally invasive operations where access is limited and reliable topical hemostasis is critical. Buyers increasingly compare products by speed of hemostasis, handling, conformability, swelling control, and compatibility with adjunct agents. Quality and compliance are major decision factors, including sterility assurance, low endotoxin, and consistent performance under regulatory scrutiny. Market competition is shifting from basic sponges toward advanced bioresorbable matrices and combination hemostats that deliver stronger efficacy in challenging bleeding sites. Pricing is influenced by hospital tenders and reimbursement rules, while supply reliability remains essential for operating room continuity. Overall, growth is supported by aging populations, chronic disease prevalence, and continuous innovation in surgical hemostasis technologies.
This report delivers a comprehensive overview of the global Hemostatic Sponge market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Hemostatic Sponge. The Hemostatic Sponge market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Hemostatic Sponge market comprehensively. Regional market sizes by Type, by Application, by Product Form, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Hemostatic Sponge manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Hemostatic Sponge Market Report

Report Metric Details
Report Name Hemostatic Sponge Market
Accounted market size in 2025 US$ 1620 million
Forecasted market size in 2032 US$ 2109 million
CAGR 4.1%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Gelatin Hemostatic Sponge
  • Collagen Hemostatic Sponge
  • Others
Segment by Product Form
  • Sponge Sheets
  • Sponge Particles
  • Others
Segment by Departments
  • ENT and Dental Surgery
  • Plastic Surgery
  • Neuro surgery
  • Others
by Application
  • Hospitals
  • Clinics
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, Johnson & Johnson, B. Braun, Gelita Medical, Cura Medical, Aegis Lifesciences, COLTENE, Dispotech, Ferrosan Medical Devices, EUCARE Pharmaceuticals, BOENMED, Medelast, JIAXING KENYUE, Medzeel Lifescience, Goodwill Lifesciences, Equimedical, Healthium Medtech, Septodont, Assut Europe, Nanchang Hushida Medical Technology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Product Form, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Hemostatic Sponge manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Hemostatic Sponge sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Hemostatic Sponge Market growing?

Ans: The Hemostatic Sponge Market witnessing a CAGR of 4.1% during the forecast period 2026-2032.

What is the Hemostatic Sponge Market size in 2032?

Ans: The Hemostatic Sponge Market size in 2032 will be US$ 2109 million.

Who are the main players in the Hemostatic Sponge Market report?

Ans: The main players in the Hemostatic Sponge Market are Pfizer, Johnson & Johnson, B. Braun, Gelita Medical, Cura Medical, Aegis Lifesciences, COLTENE, Dispotech, Ferrosan Medical Devices, EUCARE Pharmaceuticals, BOENMED, Medelast, JIAXING KENYUE, Medzeel Lifescience, Goodwill Lifesciences, Equimedical, Healthium Medtech, Septodont, Assut Europe, Nanchang Hushida Medical Technology

What are the Application segmentation covered in the Hemostatic Sponge Market report?

Ans: The Applications covered in the Hemostatic Sponge Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Hemostatic Sponge Market report?

Ans: The Types covered in the Hemostatic Sponge Market report are Gelatin Hemostatic Sponge, Collagen Hemostatic Sponge, Others

1 Hemostatic Sponge Market Overview
1.1 Product Definition
1.2 Hemostatic Sponge by Type
1.2.1 Global Hemostatic Sponge Market Value by Type: 2025 vs 2032
1.2.2 Gelatin Hemostatic Sponge
1.2.3 Collagen Hemostatic Sponge
1.2.4 Others
1.3 Hemostatic Sponge by Product Form
1.3.1 Global Hemostatic Sponge Market Value by Product Form: 2025 vs 2032
1.3.2 Sponge Sheets
1.3.3 Sponge Particles
1.3.4 Others
1.4 Hemostatic Sponge by Departments
1.4.1 Global Hemostatic Sponge Market Value by Departments: 2025 vs 2032
1.4.2 ENT and Dental Surgery
1.4.3 Plastic Surgery
1.4.4 Neuro surgery
1.4.5 Others
1.5 Hemostatic Sponge by Application
1.5.1 Global Hemostatic Sponge Market Value by Application: 2025 vs 2032
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Global Hemostatic Sponge Market Size Estimates and Forecasts
1.6.1 Global Hemostatic Sponge Revenue 2021–2032
1.6.2 Global Hemostatic Sponge Sales 2021–2032
1.6.3 Global Hemostatic Sponge Market Average Price (2021–2032)
1.7 Assumptions and Limitations
2 Hemostatic Sponge Market Competition by Manufacturers
2.1 Global Hemostatic Sponge Sales Market Share by Manufacturers (2021–2026)
2.2 Global Hemostatic Sponge Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Hemostatic Sponge Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Hemostatic Sponge, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Hemostatic Sponge, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Hemostatic Sponge, Product Types and Applications
2.7 Global Key Manufacturers of Hemostatic Sponge, Date of Entry into the Industry
2.8 Global Hemostatic Sponge Market Competitive Situation and Trends
2.8.1 Global Hemostatic Sponge Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Hemostatic Sponge Players Market Share by Revenue
2.8.3 Global Hemostatic Sponge Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Hemostatic Sponge Market Scenario by Region
3.1 Global Hemostatic Sponge Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Hemostatic Sponge Sales by Region: 2021–2032
3.2.1 Global Hemostatic Sponge Sales by Region: 2021–2026
3.2.2 Global Hemostatic Sponge Sales by Region: 2027–2032
3.3 Global Hemostatic Sponge Revenue by Region: 2021–2032
3.3.1 Global Hemostatic Sponge Revenue by Region: 2021–2026
3.3.2 Global Hemostatic Sponge Revenue by Region: 2027–2032
3.4 North America Hemostatic Sponge Market Facts & Figures by Country
3.4.1 North America Hemostatic Sponge Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Hemostatic Sponge Sales by Country (2021–2032)
3.4.3 North America Hemostatic Sponge Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Hemostatic Sponge Market Facts & Figures by Country
3.5.1 Europe Hemostatic Sponge Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Hemostatic Sponge Sales by Country (2021–2032)
3.5.3 Europe Hemostatic Sponge Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hemostatic Sponge Market Facts & Figures by Region
3.6.1 Asia Pacific Hemostatic Sponge Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Hemostatic Sponge Sales by Region (2021–2032)
3.6.3 Asia Pacific Hemostatic Sponge Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Hemostatic Sponge Market Facts & Figures by Country
3.7.1 Latin America Hemostatic Sponge Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Hemostatic Sponge Sales by Country (2021–2032)
3.7.3 Latin America Hemostatic Sponge Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hemostatic Sponge Market Facts & Figures by Country
3.8.1 Middle East and Africa Hemostatic Sponge Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Hemostatic Sponge Sales by Country (2021–2032)
3.8.3 Middle East and Africa Hemostatic Sponge Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Hemostatic Sponge Sales by Type (2021–2032)
4.1.1 Global Hemostatic Sponge Sales by Type (2021–2026)
4.1.2 Global Hemostatic Sponge Sales by Type (2027–2032)
4.1.3 Global Hemostatic Sponge Sales Market Share by Type (2021–2032)
4.2 Global Hemostatic Sponge Revenue by Type (2021–2032)
4.2.1 Global Hemostatic Sponge Revenue by Type (2021–2026)
4.2.2 Global Hemostatic Sponge Revenue by Type (2027–2032)
4.2.3 Global Hemostatic Sponge Revenue Market Share by Type (2021–2032)
4.3 Global Hemostatic Sponge Price by Type (2021–2032)
5 Segment by Application
5.1 Global Hemostatic Sponge Sales by Application (2021–2032)
5.1.1 Global Hemostatic Sponge Sales by Application (2021–2026)
5.1.2 Global Hemostatic Sponge Sales by Application (2027–2032)
5.1.3 Global Hemostatic Sponge Sales Market Share by Application (2021–2032)
5.2 Global Hemostatic Sponge Revenue by Application (2021–2032)
5.2.1 Global Hemostatic Sponge Revenue by Application (2021–2026)
5.2.2 Global Hemostatic Sponge Revenue by Application (2027–2032)
5.2.3 Global Hemostatic Sponge Revenue Market Share by Application (2021–2032)
5.3 Global Hemostatic Sponge Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Hemostatic Sponge Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Pfizer Hemostatic Sponge Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Company Information
6.2.2 Johnson & Johnson Description and Business Overview
6.2.3 Johnson & Johnson Hemostatic Sponge Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Johnson & Johnson Hemostatic Sponge Product Portfolio
6.2.5 Johnson & Johnson Recent Developments/Updates
6.3 B. Braun
6.3.1 B. Braun Company Information
6.3.2 B. Braun Description and Business Overview
6.3.3 B. Braun Hemostatic Sponge Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 B. Braun Hemostatic Sponge Product Portfolio
6.3.5 B. Braun Recent Developments/Updates
6.4 Gelita Medical
6.4.1 Gelita Medical Company Information
6.4.2 Gelita Medical Description and Business Overview
6.4.3 Gelita Medical Hemostatic Sponge Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Gelita Medical Hemostatic Sponge Product Portfolio
6.4.5 Gelita Medical Recent Developments/Updates
6.5 Cura Medical
6.5.1 Cura Medical Company Information
6.5.2 Cura Medical Description and Business Overview
6.5.3 Cura Medical Hemostatic Sponge Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Cura Medical Hemostatic Sponge Product Portfolio
6.5.5 Cura Medical Recent Developments/Updates
6.6 Aegis Lifesciences
6.6.1 Aegis Lifesciences Company Information
6.6.2 Aegis Lifesciences Description and Business Overview
6.6.3 Aegis Lifesciences Hemostatic Sponge Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Aegis Lifesciences Hemostatic Sponge Product Portfolio
6.6.5 Aegis Lifesciences Recent Developments/Updates
6.7 COLTENE
6.7.1 COLTENE Company Information
6.7.2 COLTENE Description and Business Overview
6.7.3 COLTENE Hemostatic Sponge Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 COLTENE Hemostatic Sponge Product Portfolio
6.7.5 COLTENE Recent Developments/Updates
6.8 Dispotech
6.8.1 Dispotech Company Information
6.8.2 Dispotech Description and Business Overview
6.8.3 Dispotech Hemostatic Sponge Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Dispotech Hemostatic Sponge Product Portfolio
6.8.5 Dispotech Recent Developments/Updates
6.9 Ferrosan Medical Devices
6.9.1 Ferrosan Medical Devices Company Information
6.9.2 Ferrosan Medical Devices Description and Business Overview
6.9.3 Ferrosan Medical Devices Hemostatic Sponge Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Ferrosan Medical Devices Hemostatic Sponge Product Portfolio
6.9.5 Ferrosan Medical Devices Recent Developments/Updates
6.10 EUCARE Pharmaceuticals
6.10.1 EUCARE Pharmaceuticals Company Information
6.10.2 EUCARE Pharmaceuticals Description and Business Overview
6.10.3 EUCARE Pharmaceuticals Hemostatic Sponge Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 EUCARE Pharmaceuticals Hemostatic Sponge Product Portfolio
6.10.5 EUCARE Pharmaceuticals Recent Developments/Updates
6.11 BOENMED
6.11.1 BOENMED Company Information
6.11.2 BOENMED Description and Business Overview
6.11.3 BOENMED Hemostatic Sponge Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 BOENMED Hemostatic Sponge Product Portfolio
6.11.5 BOENMED Recent Developments/Updates
6.12 Medelast
6.12.1 Medelast Company Information
6.12.2 Medelast Description and Business Overview
6.12.3 Medelast Hemostatic Sponge Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Medelast Hemostatic Sponge Product Portfolio
6.12.5 Medelast Recent Developments/Updates
6.13 JIAXING KENYUE
6.13.1 JIAXING KENYUE Company Information
6.13.2 JIAXING KENYUE Description and Business Overview
6.13.3 JIAXING KENYUE Hemostatic Sponge Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 JIAXING KENYUE Hemostatic Sponge Product Portfolio
6.13.5 JIAXING KENYUE Recent Developments/Updates
6.14 Medzeel Lifescience
6.14.1 Medzeel Lifescience Company Information
6.14.2 Medzeel Lifescience Description and Business Overview
6.14.3 Medzeel Lifescience Hemostatic Sponge Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Medzeel Lifescience Hemostatic Sponge Product Portfolio
6.14.5 Medzeel Lifescience Recent Developments/Updates
6.15 Goodwill Lifesciences
6.15.1 Goodwill Lifesciences Company Information
6.15.2 Goodwill Lifesciences Description and Business Overview
6.15.3 Goodwill Lifesciences Hemostatic Sponge Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Goodwill Lifesciences Hemostatic Sponge Product Portfolio
6.15.5 Goodwill Lifesciences Recent Developments/Updates
6.16 Equimedical
6.16.1 Equimedical Company Information
6.16.2 Equimedical Description and Business Overview
6.16.3 Equimedical Hemostatic Sponge Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Equimedical Hemostatic Sponge Product Portfolio
6.16.5 Equimedical Recent Developments/Updates
6.17 Healthium Medtech
6.17.1 Healthium Medtech Company Information
6.17.2 Healthium Medtech Description and Business Overview
6.17.3 Healthium Medtech Hemostatic Sponge Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Healthium Medtech Hemostatic Sponge Product Portfolio
6.17.5 Healthium Medtech Recent Developments/Updates
6.18 Septodont
6.18.1 Septodont Company Information
6.18.2 Septodont Description and Business Overview
6.18.3 Septodont Hemostatic Sponge Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Septodont Hemostatic Sponge Product Portfolio
6.18.5 Septodont Recent Developments/Updates
6.19 Assut Europe
6.19.1 Assut Europe Company Information
6.19.2 Assut Europe Description and Business Overview
6.19.3 Assut Europe Hemostatic Sponge Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 Assut Europe Hemostatic Sponge Product Portfolio
6.19.5 Assut Europe Recent Developments/Updates
6.20 Nanchang Hushida Medical Technology
6.20.1 Nanchang Hushida Medical Technology Company Information
6.20.2 Nanchang Hushida Medical Technology Description and Business Overview
6.20.3 Nanchang Hushida Medical Technology Hemostatic Sponge Sales, Revenue, and Gross Margin (2021–2026)
6.20.4 Nanchang Hushida Medical Technology Hemostatic Sponge Product Portfolio
6.20.5 Nanchang Hushida Medical Technology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hemostatic Sponge Industry Chain Analysis
7.2 Hemostatic Sponge Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hemostatic Sponge Production Mode & Process Analysis
7.4 Hemostatic Sponge Sales and Marketing
7.4.1 Hemostatic Sponge Sales Channels
7.4.2 Hemostatic Sponge Distributors
7.5 Hemostatic Sponge Customer Analysis
8 Hemostatic Sponge Market Dynamics
8.1 Hemostatic Sponge Industry Trends
8.2 Hemostatic Sponge Market Drivers
8.3 Hemostatic Sponge Market Challenges
8.4 Hemostatic Sponge Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Hemostatic Sponge Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Hemostatic Sponge Market Value by Product Form (US$ Million), 2025 vs 2032
 Table 3. Global Hemostatic Sponge Market Value by Departments (US$ Million), 2025 vs 2032
 Table 4. Global Hemostatic Sponge Market Value by Application (US$ Million), 2025 vs 2032
 Table 5. Global Hemostatic Sponge Market Competitive Situation by Manufacturers in 2025
 Table 6. Global Hemostatic Sponge Sales (K Units) of Key Manufacturers (2021–2026)
 Table 7. Global Hemostatic Sponge Sales Market Share by Manufacturers (2021–2026)
 Table 8. Global Hemostatic Sponge Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 9. Global Hemostatic Sponge Revenue Share by Manufacturers (2021–2026)
 Table 10. Global Market Hemostatic Sponge Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 11. Global Key Players of Hemostatic Sponge, Industry Ranking, 2023 vs 2024 vs 2025
 Table 12. Global Key Manufacturers of Hemostatic Sponge, Manufacturing Sites and Headquarters
 Table 13. Global Key Manufacturers of Hemostatic Sponge, Product Types and Applications
 Table 14. Global Key Manufacturers of Hemostatic Sponge, Date of Entry into the Industry
 Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 16. Global Hemostatic Sponge Companies by Tier (Tier 1, Tier 2, Tier 3), based on Hemostatic Sponge Revenue, 2025
 Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 18. Global Hemostatic Sponge Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 19. Global Hemostatic Sponge Sales by Region (K Units), 2021–2026
 Table 20. Global Hemostatic Sponge Sales Market Share by Region (2021–2026)
 Table 21. Global Hemostatic Sponge Sales by Region (K Units), 2027–2032
 Table 22. Global Hemostatic Sponge Sales Market Share by Region (2027–2032)
 Table 23. Global Hemostatic Sponge Revenue by Region (US$ Million), 2021–2026
 Table 24. Global Hemostatic Sponge Revenue Market Share by Region (2021–2026)
 Table 25. Global Hemostatic Sponge Revenue by Region (US$ Million), 2027–2032
 Table 26. Global Hemostatic Sponge Revenue Market Share by Region (2027–2032)
 Table 27. North America Hemostatic Sponge Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 28. North America Hemostatic Sponge Sales by Country (K Units), 2021–2026
 Table 29. North America Hemostatic Sponge Sales by Country (K Units), 2027–2032
 Table 30. North America Hemostatic Sponge Revenue by Country (US$ Million), 2021–2026
 Table 31. North America Hemostatic Sponge Revenue by Country (US$ Million), 2027–2032
 Table 32. Europe Hemostatic Sponge Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 33. Europe Hemostatic Sponge Sales by Country (K Units), 2021–2026
 Table 34. Europe Hemostatic Sponge Sales by Country (K Units), 2027–2032
 Table 35. Europe Hemostatic Sponge Revenue by Country (US$ Million), 2021–2026
 Table 36. Europe Hemostatic Sponge Revenue by Country (US$ Million), 2027–2032
 Table 37. Asia Pacific Hemostatic Sponge Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 38. Asia Pacific Hemostatic Sponge Sales by Region (K Units), 2021–2026
 Table 39. Asia Pacific Hemostatic Sponge Sales by Region (K Units), 2027–2032
 Table 40. Asia Pacific Hemostatic Sponge Revenue by Region (US$ Million), 2021–2026
 Table 41. Asia Pacific Hemostatic Sponge Revenue by Region (US$ Million), 2027–2032
 Table 42. Latin America Hemostatic Sponge Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 43. Latin America Hemostatic Sponge Sales by Country (K Units), 2021–2026
 Table 44. Latin America Hemostatic Sponge Sales by Country (K Units), 2027–2032
 Table 45. Latin America Hemostatic Sponge Revenue by Country (US$ Million), 2021–2026
 Table 46. Latin America Hemostatic Sponge Revenue by Country (US$ Million), 2027–2032
 Table 47. Middle East and Africa Hemostatic Sponge Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 48. Middle East and Africa Hemostatic Sponge Sales by Country (K Units), 2021–2026
 Table 49. Middle East and Africa Hemostatic Sponge Sales by Country (K Units), 2027–2032
 Table 50. Middle East and Africa Hemostatic Sponge Revenue by Country (US$ Million), 2021–2026
 Table 51. Middle East and Africa Hemostatic Sponge Revenue by Country (US$ Million), 2027–2032
 Table 52. Global Hemostatic Sponge Sales (K Units) by Type (2021–2026)
 Table 53. Global Hemostatic Sponge Sales (K Units) by Type (2027–2032)
 Table 54. Global Hemostatic Sponge Sales Market Share by Type (2021–2026)
 Table 55. Global Hemostatic Sponge Sales Market Share by Type (2027–2032)
 Table 56. Global Hemostatic Sponge Revenue (US$ Million) by Type (2021–2026)
 Table 57. Global Hemostatic Sponge Revenue (US$ Million) by Type (2027–2032)
 Table 58. Global Hemostatic Sponge Revenue Market Share by Type (2021–2026)
 Table 59. Global Hemostatic Sponge Revenue Market Share by Type (2027–2032)
 Table 60. Global Hemostatic Sponge Price (US$/Unit) by Type (2021–2026)
 Table 61. Global Hemostatic Sponge Price (US$/Unit) by Type (2027–2032)
 Table 62. Global Hemostatic Sponge Sales (K Units) by Application (2021–2026)
 Table 63. Global Hemostatic Sponge Sales (K Units) by Application (2027–2032)
 Table 64. Global Hemostatic Sponge Sales Market Share by Application (2021–2026)
 Table 65. Global Hemostatic Sponge Sales Market Share by Application (2027–2032)
 Table 66. Global Hemostatic Sponge Revenue (US$ Million) by Application (2021–2026)
 Table 67. Global Hemostatic Sponge Revenue (US$ Million) by Application (2027–2032)
 Table 68. Global Hemostatic Sponge Revenue Market Share by Application (2021–2026)
 Table 69. Global Hemostatic Sponge Revenue Market Share by Application (2027–2032)
 Table 70. Global Hemostatic Sponge Price (US$/Unit) by Application (2021–2026)
 Table 71. Global Hemostatic Sponge Price (US$/Unit) by Application (2027–2032)
 Table 72. Pfizer Company Information
 Table 73. Pfizer Description and Business Overview
 Table 74. Pfizer Hemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 75. Pfizer Hemostatic Sponge Product
 Table 76. Pfizer Recent Developments/Updates
 Table 77. Johnson & Johnson Company Information
 Table 78. Johnson & Johnson Description and Business Overview
 Table 79. Johnson & Johnson Hemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 80. Johnson & Johnson Hemostatic Sponge Product
 Table 81. Johnson & Johnson Recent Developments/Updates
 Table 82. B. Braun Company Information
 Table 83. B. Braun Description and Business Overview
 Table 84. B. Braun Hemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 85. B. Braun Hemostatic Sponge Product
 Table 86. B. Braun Recent Developments/Updates
 Table 87. Gelita Medical Company Information
 Table 88. Gelita Medical Description and Business Overview
 Table 89. Gelita Medical Hemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 90. Gelita Medical Hemostatic Sponge Product
 Table 91. Gelita Medical Recent Developments/Updates
 Table 92. Cura Medical Company Information
 Table 93. Cura Medical Description and Business Overview
 Table 94. Cura Medical Hemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 95. Cura Medical Hemostatic Sponge Product
 Table 96. Cura Medical Recent Developments/Updates
 Table 97. Aegis Lifesciences Company Information
 Table 98. Aegis Lifesciences Description and Business Overview
 Table 99. Aegis Lifesciences Hemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 100. Aegis Lifesciences Hemostatic Sponge Product
 Table 101. Aegis Lifesciences Recent Developments/Updates
 Table 102. COLTENE Company Information
 Table 103. COLTENE Description and Business Overview
 Table 104. COLTENE Hemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 105. COLTENE Hemostatic Sponge Product
 Table 106. COLTENE Recent Developments/Updates
 Table 107. Dispotech Company Information
 Table 108. Dispotech Description and Business Overview
 Table 109. Dispotech Hemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 110. Dispotech Hemostatic Sponge Product
 Table 111. Dispotech Recent Developments/Updates
 Table 112. Ferrosan Medical Devices Company Information
 Table 113. Ferrosan Medical Devices Description and Business Overview
 Table 114. Ferrosan Medical Devices Hemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 115. Ferrosan Medical Devices Hemostatic Sponge Product
 Table 116. Ferrosan Medical Devices Recent Developments/Updates
 Table 117. EUCARE Pharmaceuticals Company Information
 Table 118. EUCARE Pharmaceuticals Description and Business Overview
 Table 119. EUCARE Pharmaceuticals Hemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 120. EUCARE Pharmaceuticals Hemostatic Sponge Product
 Table 121. EUCARE Pharmaceuticals Recent Developments/Updates
 Table 122. BOENMED Company Information
 Table 123. BOENMED Description and Business Overview
 Table 124. BOENMED Hemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 125. BOENMED Hemostatic Sponge Product
 Table 126. BOENMED Recent Developments/Updates
 Table 127. Medelast Company Information
 Table 128. Medelast Description and Business Overview
 Table 129. Medelast Hemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 130. Medelast Hemostatic Sponge Product
 Table 131. Medelast Recent Developments/Updates
 Table 132. JIAXING KENYUE Company Information
 Table 133. JIAXING KENYUE Description and Business Overview
 Table 134. JIAXING KENYUE Hemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 135. JIAXING KENYUE Hemostatic Sponge Product
 Table 136. JIAXING KENYUE Recent Developments/Updates
 Table 137. Medzeel Lifescience Company Information
 Table 138. Medzeel Lifescience Description and Business Overview
 Table 139. Medzeel Lifescience Hemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 140. Medzeel Lifescience Hemostatic Sponge Product
 Table 141. Medzeel Lifescience Recent Developments/Updates
 Table 142. Goodwill Lifesciences Company Information
 Table 143. Goodwill Lifesciences Description and Business Overview
 Table 144. Goodwill Lifesciences Hemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 145. Goodwill Lifesciences Hemostatic Sponge Product
 Table 146. Goodwill Lifesciences Recent Developments/Updates
 Table 147. Equimedical Company Information
 Table 148. Equimedical Description and Business Overview
 Table 149. Equimedical Hemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 150. Equimedical Hemostatic Sponge Product
 Table 151. Equimedical Recent Developments/Updates
 Table 152. Healthium Medtech Company Information
 Table 153. Healthium Medtech Description and Business Overview
 Table 154. Healthium Medtech Hemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 155. Healthium Medtech Hemostatic Sponge Product
 Table 156. Healthium Medtech Recent Developments/Updates
 Table 157. Septodont Company Information
 Table 158. Septodont Description and Business Overview
 Table 159. Septodont Hemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 160. Septodont Hemostatic Sponge Product
 Table 161. Septodont Recent Developments/Updates
 Table 162. Assut Europe Company Information
 Table 163. Assut Europe Description and Business Overview
 Table 164. Assut Europe Hemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 165. Assut Europe Hemostatic Sponge Product
 Table 166. Assut Europe Recent Developments/Updates
 Table 167. Nanchang Hushida Medical Technology Company Information
 Table 168. Nanchang Hushida Medical Technology Description and Business Overview
 Table 169. Nanchang Hushida Medical Technology Hemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 170. Nanchang Hushida Medical Technology Hemostatic Sponge Product
 Table 171. Nanchang Hushida Medical Technology Recent Developments/Updates
 Table 172. Key Raw Materials Lists
 Table 173. Raw Materials Key Suppliers Lists
 Table 174. Hemostatic Sponge Distributors List
 Table 175. Hemostatic Sponge Customers List
 Table 176. Hemostatic Sponge Market Trends
 Table 177. Hemostatic Sponge Market Drivers
 Table 178. Hemostatic Sponge Market Challenges
 Table 179. Hemostatic Sponge Market Restraints
 Table 180. Research Programs/Design for This Report
 Table 181. Key Data Information from Secondary Sources
 Table 182. Key Data Information from Primary Sources
 Table 183. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Hemostatic Sponge
 Figure 2. Global Hemostatic Sponge Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Hemostatic Sponge Market Share by Type: 2025 & 2032
 Figure 4. Gelatin Hemostatic Sponge Product Picture
 Figure 5. Collagen Hemostatic Sponge Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Hemostatic Sponge Market Value by Product Form (US$ Million), 2021–2032
 Figure 8. Global Hemostatic Sponge Market Share by Product Form: 2025 vs 2032
 Figure 9. Sponge Sheets Product Picture
 Figure 10. Sponge Particles Product Picture
 Figure 11. Others Product Picture
 Figure 12. Global Hemostatic Sponge Market Value by Departments (US$ Million), 2021–2032
 Figure 13. Global Hemostatic Sponge Market Share by Departments: 2025 vs 2032
 Figure 14. ENT and Dental Surgery Product Picture
 Figure 15. Plastic Surgery Product Picture
 Figure 16. Neuro surgery Product Picture
 Figure 17. Others Product Picture
 Figure 18. Global Hemostatic Sponge Market Value by Application (US$ Million), 2021–2032
 Figure 19. Global Hemostatic Sponge Market Share by Application: 2025 & 2032
 Figure 20. Hospitals
 Figure 21. Clinics
 Figure 22. Others
 Figure 23. Global Hemostatic Sponge Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 24. Global Hemostatic Sponge Market Size (US$ Million), 2021–2032
 Figure 25. Global Hemostatic Sponge Sales (K Units), 2021–2032
 Figure 26. Global Hemostatic Sponge Average Price (US$/Unit), 2021–2032
 Figure 27. Hemostatic Sponge Report Years Considered
 Figure 28. Hemostatic Sponge Sales Share by Manufacturers in 2025
 Figure 29. Global Hemostatic Sponge Revenue Share by Manufacturers in 2025
 Figure 30. Top 5 and Top 10 Global Hemostatic Sponge Players: Market Share by Revenue in Hemostatic Sponge in 2025
 Figure 31. Hemostatic Sponge Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 32. Global Hemostatic Sponge Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 33. North America Hemostatic Sponge Sales Market Share by Country (2021–2032)
 Figure 34. North America Hemostatic Sponge Revenue Market Share by Country (2021–2032)
 Figure 35. U.S. Hemostatic Sponge Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Canada Hemostatic Sponge Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Europe Hemostatic Sponge Sales Market Share by Country (2021–2032)
 Figure 38. Europe Hemostatic Sponge Revenue Market Share by Country (2021–2032)
 Figure 39. Germany Hemostatic Sponge Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. France Hemostatic Sponge Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. U.K. Hemostatic Sponge Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Italy Hemostatic Sponge Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Russia Hemostatic Sponge Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Asia Pacific Hemostatic Sponge Sales Market Share by Region (2021–2032)
 Figure 45. Asia Pacific Hemostatic Sponge Revenue Market Share by Region (2021–2032)
 Figure 46. China Hemostatic Sponge Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Japan Hemostatic Sponge Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. South Korea Hemostatic Sponge Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. India Hemostatic Sponge Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Australia Hemostatic Sponge Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Taiwan Hemostatic Sponge Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Indonesia Hemostatic Sponge Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Thailand Hemostatic Sponge Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Malaysia Hemostatic Sponge Revenue Growth Rate (US$ Million), 2021–2032
 Figure 55. Philippines Hemostatic Sponge Revenue Growth Rate (US$ Million), 2021–2032
 Figure 56. Latin America Hemostatic Sponge Sales Market Share by Country (2021–2032)
 Figure 57. Latin America Hemostatic Sponge Revenue Market Share by Country (2021–2032)
 Figure 58. Mexico Hemostatic Sponge Revenue Growth Rate (US$ Million), 2021–2032
 Figure 59. Brazil Hemostatic Sponge Revenue Growth Rate (US$ Million), 2021–2032
 Figure 60. Argentina Hemostatic Sponge Revenue Growth Rate (US$ Million), 2021–2032
 Figure 61. Middle East and Africa Hemostatic Sponge Sales Market Share by Country (2021–2032)
 Figure 62. Middle East and Africa Hemostatic Sponge Revenue Market Share by Country (2021–2032)
 Figure 63. Turkey Hemostatic Sponge Revenue Growth Rate (US$ Million), 2021–2032
 Figure 64. Saudi Arabia Hemostatic Sponge Revenue Growth Rate (US$ Million), 2021–2032
 Figure 65. U.A.E Hemostatic Sponge Revenue Growth Rate (US$ Million), 2021–2032
 Figure 66. Global Sales Market Share of Hemostatic Sponge by Type (2021–2032)
 Figure 67. Global Revenue Market Share of Hemostatic Sponge by Type (2021–2032)
 Figure 68. Global Hemostatic Sponge Price (US$/Unit) by Type (2021–2032)
 Figure 69. Global Sales Market Share of Hemostatic Sponge by Application (2021–2032)
 Figure 70. Global Revenue Market Share of Hemostatic Sponge by Application (2021–2032)
 Figure 71. Global Hemostatic Sponge Price (US$/Unit) by Application (2021–2032)
 Figure 72. Hemostatic Sponge Value Chain
 Figure 73. Channels of Distribution (Direct Vs Distribution)
 Figure 74. Bottom-up and Top-down Approaches for This Report
 Figure 75. Data Triangulation
 Figure 76. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS